Hormone-sensitive prostate cancer Pfizer Astellas

Pfizer and Astellas modify research protocols for ARCHES and EMBARK

Pfizer and Astellas Pharma have amended the protocols of two registrational Phase lll trials, ARCHES and EMBARK, which aim to…